<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A retrospective analysis of clinicohematologic parameters of 25 patients with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> was carried out </plain></SENT>
<SENT sid="1" pm="."><plain>The hematologic tests included dilute Russel viper venom test (dRVVT), kaolin clotting time (KCT), activated partial thromboplastin time, and prothrombin time </plain></SENT>
<SENT sid="2" pm="."><plain>The diagnosis of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> was based on the presence of prolonged KCT/dRVVT, its absence of correction with <z:mpath ids='MPATH_458'>normal</z:mpath> plasma and correction by <z:chebi fb="1" ids="16247">phospholipids</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Specific factor assays and platelet aggregation studies were performed wherever required </plain></SENT>
<SENT sid="4" pm="."><plain>Ten patients (40%) had <z:mp ids='MP_0005048'>thrombosis</z:mp>, which was venous in 5 (50%) and arterial in 4 (40%) </plain></SENT>
<SENT sid="5" pm="."><plain>One patient (10%) had both arterial and <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> and presented with catastrophic <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Eighteen female patients conceived </plain></SENT>
<SENT sid="7" pm="."><plain>Four (22%) of these had recurrent first trimester abortion </plain></SENT>
<SENT sid="8" pm="."><plain>Five (20%) patients had <z:mp ids='MP_0001914'>bleeding</z:mp> manifestations </plain></SENT>
<SENT sid="9" pm="."><plain>One (4%) of these had <z:e sem="disease" ids="C0020640" disease_type="Disease or Syndrome" abbrv="">hypoprothrombinemia</z:e> and was diagnosed to have <z:e sem="disease" ids="C0020640" disease_type="Disease or Syndrome" abbrv="">hypoprothrombinemia</z:e> <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> syndrome </plain></SENT>
<SENT sid="10" pm="."><plain>However in two of these patients, no cause of <z:mp ids='MP_0001914'>bleeding</z:mp> could be identified other than the presence of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> </plain></SENT>
<SENT sid="11" pm="."><plain>It is concluded that patients with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> have a varied spectrum of <z:e sem="disease" ids="C0005779" disease_type="Disease or Syndrome" abbrv="">hemostatic disorders</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain><z:mp ids='MP_0001914'>Bleeding</z:mp> may sometimes occur in these patients due to associated <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> or associated factor inhibitors </plain></SENT>
<SENT sid="13" pm="."><plain>Rarely, it may occur due to presence of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> alone </plain></SENT>
</text></document>